MAZZAGLIA GIAMPIERO

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2025). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA, 62(3), 343-351 [10.1007/s00592-024-02359-1]. Dettaglio

Mazzaglia, G., Antonazzo, I., Mol, P. (2024). Risk management and drug utilization research. In Drug Utilization Research: Methods and Applications (pp. 428-436). wiley [10.1002/9781119911685.ch42]. Dettaglio

Mueller, T., Mazzaglia, G., Carlos E., D. (2024). Intervention studies in drug utilisation research. In B.W. Monique Elseviers (a cura di), Drug Utilization Research: Methods and Applications - Second Edition (pp. 73-81). wiley [10.1002/9781119911685.ch7]. Dettaglio

Cortesi, P., Antonazzo, I., Palladino, P., Gnesi, M., Mele, S., D’Amelio, M., et al. (2024). Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis. ACTA DIABETOLOGICA, 61(8), 1017-1028 [10.1007/s00592-024-02276-3]. Dettaglio

Antonazzo, I., Rozza, D., Conti, S., Fornari, C., Cortesi, P., Eteve-Pitsaer, C., et al. (2024). Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database. EUROPEAN JOURNAL OF NEUROLOGY, 31(1 (January 2024)) [10.1111/ene.16064]. Dettaglio